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Abstract 
 
The nucleus of a cell is separated from the cytoplasm by the nuclear envelope, which consists of 
an inner and outer membrane. The inner nuclear membrane (INM) is home to many proteins. Genetic 
disorders referred to as “laminopathies”, which include cardiac and skeletal myopathies, partial 
lipodystrophy, peripheral neuropathy, and severe premature aging, are caused by failure to 
correctly localize proteins to the inner nuclear membrane (INM). To study the process by which 
peripheral proteins arrive at and are maintained at the INM, I have employed a yeast model 
system using TRM1-II as a reporter. In yeast, Trm1-II, a tRNA methyltransferase, is peripherally 
associated with the INM. Previous studies determined that the Trm1 amino acid region 130-151 
is necessary and sufficient for INM targeting (Lai et al., 2009). This is the first peptide motif 
discovered that has INM targeting activity. In order to determine which amino acids within the 
motif are important for INM targeting, I performed a random mutagenesis screen. The results 
suggest that structural features of this motif are responsible for the targeting of Trm1-II to the 
INM. Structural analysis of archeal Trm1 revealed that an -helix is formed by amino acids 145-
153. This -helix is amphipathic (ie. one side of the helix is comprised of polar residues, while 
the other is comprised of nonpolar residues). Since amino acid changes that affect the 
amphipathic property of the -helix resulted in the mislocalization of Trm1-II to the 
nucleoplasm, I proposed that the amphipathic property of the helix is important for the INM 
targeting activity of this motif. In order to test this, I am performing site-directed mutagenesis on 
speicific amino acids within the -helix to generate mutations that result in the destruction of the 
amphipathic property of the -helix. I will then assay the impact of these mutations upon the 
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localization of Trm1-II. After refining the description of the important properties of this motif, 
future work will include searching other INM proteins for similar domains and testing whether 
mutations of these domains cause mislocalization of the proteins. This will help provide 
important information regarding the targeting mechanism of peripherally associated nuclear 
membrane proteins.  
 
Chapter 1: Introduction 
Eukaryotic cells have a membrane-bound nucleus that is essential for the life of the cell 
(Fig. 1). The nucleus is enclosed by the nuclear envelope, which is made up of an inner nuclear 
membrane (INM) and an outer nuclear membrane. Both the inner nuclear membrane and outer 
nuclear membrane are comprised of diverse groups of proteins. For example, nuclear pore 
complexes are made up of both integral membrane proteins that are located in the nuclear 
membrane and peripherally associated proteins that are located on the nuclear membrane. 
Another important subset of proteins specifically localizes to the INM, and these proteins are 
important for several functions. In fact, these INM proteins have been shown to play many vital 
roles in nuclear function, including chromatin organization, gene expression, and DNA 
metabolism (Hetzer, 2010). Specifically, INM proteins have been recently found to function as 
“transcription factor magnets’ by sequestering transcription factors to the INM, which reduces 
the transactivation and transrepression activites of the factors” (Heessen, 2007). 
 In order for the inner nuclear membrane proteins to perform their vital roles in nuclear 
function, it is critical for them to achieve their proper subcellular destination. Failure to locate 
properly may lead to the loss of function, which can subsequently lead to disease. For example, 
greater than sixty genetic disorders, known as laminopathies, are caused by failure to correctly 
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localize proteins to the INM. Some examples of these disorders are cardiac and skeletal 
myopathies, partial lipodystrophy, peripheral neuropathy, and severe premature aging (Worman 
and Boone, 2007; Parnaik, 2008).  
The INM contains two types of proteins, integral membrane proteins, which contain a 
transmembrane domain, and peripheral membrane proteins. In order to understand the genetic 
disorders that are caused by the mislocalization of INM proteins, it is important to learn how 
these proteins achieve their correct subcellular location. While much is still unknown, models 
have been proposed for the mechanism by which integral membrane proteins target to the INM. 
It is thought that integral membrane proteins that are synthesized on and anchored to the 
endoplasmic reticulum (ER) are directed from the ER/outer nuclear membrane to the INM via 
nuclear pore lateral channels (Soullam and Worman, 1995). Important studies in yeast have 
demonstrated that Heh1/Heh2 integral, INM proteins are directed from the ER to nuclear pores 
via a process requiring the Ran pathway, the nuclear localization signals (NLS) in Heh1/Heh2 
proteins, and the karyopherins, importin-α and importin-β, that interact with these NLSs (King et 
al. , 2006). While some information regarding the targeting of integral membrane proteins to the 
INM is known, very little has been discovered about the targeting of peripherally associated INM 
proteins to this location. Since there are hundreds of peripherally associated INM proteins, many 
of which are very important for nuclear structure and organization, it is important for researchers 
to gain insight into the mechanism by which these proteins achieve the correct subcellular 
destination.   
The budding yeast, Saccharomyces cerevisiae, is an extremely useful model organism to 
study the nucleus and nuclear membrane. One important property of S. cerevisiae that makes it a 
strong model for such studies is the fact that it undergoes a closed mitosis. During a closed 
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mitosis, the chromosomes divide within an intact nuclear membrane. Higher eukaryotes undergo 
an open mitosis during which the nuclear membrane breaks down before the chromosomes 
separate and then the membrane reassembles. A plethora of tools have been developed for the 
study of cell biology and genetics in yeast. Also, Saccharomyces cerevisiae has a sequenced 
genome, is easy to maintain, and is readily available. Most importantly, there is evidence 
suggesting that similar mechanisms for nuclear organization are shared between yeast and higher 
eukaryotes. For example, nuclear lamins, which are found in higher eukaryotes but not yeast, 
localized to the nuclear periphery when expressed in yeast, suggesting the possibility of 
conservation in mechanism (Smith and Blobel, 1994). The mislocalization of lamins in higher 
eukaryotes is responsible for the genetic disorders known as laminopathies. Discoveries in yeast 
regarding INM protein localization, therefore, have the potential to provide information that is to 
relevant these diseases.  
Trm1, a tRNA methyltransferase, has been used as a reporter to study INM targeting of 
peripheral membrane proteins. In wild-type cells, two forms of the Trm1 protein are generated 
by alternative translation starts (Ellis et al., 1987). The longer form of the protein, Trm1-I, 
appears to be exclusively located in the mitochondria. Trm1-II, the shorter form of the protein, is 
located both in nuclei and in mitochondria, but it is predominantly located in the nucleus. Trm1-
II is evenly distributed on the INM in wild-type cells. Several lines of evidence have 
demonstrated Trm1-II is peripherally associated to the INM (Rose et al., 1992; Murthi and 
Hopper, 2005). For example, Trm1 does not have a transmembrane domain, and it is released 
from the INM by reagents that release peripheral proteins. 
Recent research has demonstrated that Trm1 contains a cis-acting motif that is necessary 
and sufficient for its targeting to the INM (Lai et al., 2009). Trm1 amino acids 130-151 have 
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been shown to make up this motif. When this region is deleted from the wild-type Trm1, the 
protein mislocalizes to the nucleoplasm instead of targeting to the INM. These data show that 
Trm1 amino acids 130-151 are necessary for INM targeting. When this amino acid region is 
fused with three other reporter proteins (β-galactosidase, GFP, or Trm7-GFP) the proteins target 
to the INM instead of the nucleoplasm. These data show that Trm1 amino acids 130-151 are also 
sufficient for INM targeting. When specific amino acids within this 130-151 region were 
randomly mutated, some of the mutations caused protein mislocalization to the nucleoplasm 
(Fig. 2; see amino acid changes above the Trm1 wild-type protein sequence). This supports the 
idea that the Trm1 amino acids 130-151 may be a targeting/tethering motif that is responsible for 
the targeting of Trm1 to the inner nuclear membrane.  
These and other data provide a three-step model for how Trm1 localizes to the INM (Fig. 
3). The first step of this model is entry into the nucleoplasm. The second step is the targeting of 
Trm1 to a specific spot on the INM. The third and final step is the spreading of Trm1 around the 
INM. The Trm1 peptide INM targeting motif likely functions in step two or three of this 
mechanism. The Trm1-II (130-151) region was the first peptide discovered to have INM 
targeting activity. 
A targeting peptide motif can be either amino acid sequence specific or structure specific. 
If a motif is sequence specific, then certain amino acids are required at a specific location within 
the motif in order for it to function properly. Some excellent examples of amino acid specific 
motifs are nuclear localization sequences, which are often sequences that are rich in positively 
charged amino acids. Conversely, if a motif is structure specific, then some aspect of the protein 
structure that is formed by the motif is important for it to function properly.  An example of a 
structure specific motif is the mitochondrial targeting sequence (MTS), which forms an 
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amphipathic α-helix with positively charged residues on one side and uncharged hydrophobic 
residues on the opposite side (Pfanner, 2000).   
The overall goal of this research study is to determine how peripherally associated 
proteins target to the INM. Other proteins in yeast, as well as higher eukaryotes, may employ a 
similar mechanism or may have a similar motif that is responsible for their INM targeting. If this 
is the case, learning which properties of the Trm1 motif are important for INM targeting will 
potentially have a significant impact on the understanding of the targeting of other proteins to the 
INM.  In an attempt to further characterize the Trm1-II targeting/tethering motif, a random 
mutagenesis screen was carried out, in which greater than sixty mutations causing various amino 
acid changes were created within the 130-151 region. The localization of Trm1, tagged with 
green fluorescent protein (GFP), was observed using fluorescence microscopy. Results of the 
screen were analyzed to determine which amino acids within the 130-151 region are important 
for the INM targeting function of the motif. Moreover, the question of whether the motif is 
sequence specific or structure specific was addressed.  
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Figure 1 
 
   Figure 1: Top: Schematic representation of the yeast cell; bottom: schematic    
   representation of the nucleus. (Greetchen Diaz with permission) 
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Figure 2 
 
 
Figure 2: Green box indicates the area of Trm1 in eukaryotic but not Archael counterparts; 
Magenta box indicates sequences highly conserved in all Trm1 proteins. Mutations that alter the 
wild-type localization of Trm1 are listed above the wild-type sequence. Those changes that have 
no effect upon Trm1 localization are indicated below the sequence. 
 
 
Figure 3 
 
 
A.                                                          B.                                                    C. 
 
 
Figure 3: The 3-step model for how Trm1 targets to the INM. A. NLS-mediated entry into the 
nucleoplasm. B. Trm1 targets to a spot on the INM. C. Trm1 spreads around the INM.  (Purple- 
INM; Green- Trm1-II-GFP) 
  
.  
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Table 1- Oligonucleotides used for site-directed mutagenesis 
Name Sequence (5’-3’) Source 
JP001/TPL117 (Trm1-148+) 5’- ATTAGGTATGCTCATGAAATTCCC – 3’ This study 
JP002/TPL118 (R146S) 5’- GGCTGATAACCCAGTGGCTGA- 3’ This study 
JP003/TPL119 (R146E) 5’ – GGCTTCTAACCCAGTGGCTGA – 3’ This study 
JP004/TPL120 (R146W) 5’- GGCCCATAACCCAGTGGCTGA-3’ This study 
JP005/TPL121 (A147R) 5’- GCGTCTTAACCCAGTGGCTGA – 3’ This study 
JP006/TPL122 (A147W) 5’ – CCATCTTAACCCAGTGGCTGA – 3’ This study 
JP007/TPL123 (Trm1-152+) 5’- CATGAAATTCCCCATGTGAGGGAA-3’ This study 
JP008/TPL124 (R149S) 5’ – AGCATACGAAATGGCTCTTAA- 3’ This study 
JP009/TPL125 (R149E) 5’- AGCATACTCAATGGCTCTTAA- 3’ This study 
JP010/TPL126 (A151W) 5’- CCAATACCTAATGGCTCTTAA-3’ This study 
JP011/TPL127 (A151K) 5-TTTATACCTAATGGCTCTTAA – 3’ This study 
T7 5’-TAATACGACTCACTATAGGG-3’ pGEM kit, Promega 
SP6 5’-TATTTAGGTGACACTATAG-3’ pGEM kit, Promega 
 
Chapter 2: Materials and Methods 
  
 
Strains and Media 
BY4741 (MAT-α) was used for all yeast experiments. Cells were grown in yeast extract peptone 
dextrose media (YEPD). After yeast transformation, strains were grown at 30̊ C for 2 days on 
defined media lacking uracil. For galactose induction, cells were grown for 2 days at 30̊ C on 
media lacking uracil and containing raffanose as the carbon source. Transcription of Trm1 is 
regulated by the GAL-promoter which was induced for two hours using 1/10 volume of 20% 
galactose. E. coli cells were grown in LB media with ampicilin or on LB+Amp plates at 37̊C. 
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Plasmids 
-pGP54a-Trm1-II-GFP 
-pGEMt 
 
Random Mutagenesis 
Error prone mutagenesis was performed using a GeneMorph® II EZClone Domain Mutagenesis 
Kit  (Stratagene)  to generate random mutations of Trm1 amino acids 126-151. Error prone PCR 
was performed under the following conditions: 1 cycle, 2 min. at 95̊ C; 30 cycles, 30 sec at 95̊ C, 
30 sec at 60̊ C, 1 min at 72̊ C; 1 cycle, 10 min at 72̊ C using pGP54a-Trm1-II-GFP as the 
template. This created a library containing 1-5 nucleotide mutations in the region encoding 
amino acids 130-151, which was subsequently used as a mega primer to introduce the mutations 
into wild-type TRM1 in plasmid pGP54a-Trm1-II-GFP following the instructions provided by 
Stratagene. The PCR product was then digested with Dpn1 to destroy the nonmutated donor 
plasmid DNA. The plasmid library was then transformed into E. coli (as described below). (See 
Fig 4 for method) 
 
Plasmid DNA Purification 
Qiagen’s QIAprep Miniprep kit was used for all plasmid DNA purification. Liquid cultures of E. 
coli cells containing the plasmid were grown overnight at 37̊C. The bacteria cells were first lysed 
under alkaline conditions. The lysate was subsequently neutralized and adjusted to high-salt 
binding conditions. The plasmid was then adsorbed in a QIAprep column to a silica membrane in 
a high-salt buffer. Endonucleases were then removed with a brief wash step. A second wash step 
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with a buffer containing ethanol was used to remove salt. The plasmid DNA was then eluted 
from the QIAprep column. 
 
 
E. coli Transformation 
Plasmids were added to chemical competent cells. The cells were kept on ice for 30 minutes and 
then heat shocked at 42̊ C for 45 seconds. Cells were subsequently put on ice for one minute for 
recovery. The cells were then grown in nutrient rich SOC media at 37̊C for one hour. Finally, the 
cells were plated on YT+Amp media for plasmid selection (as the plasmids were Amp-resistant) 
and grown overnight at 37̊C.  
 
Yeast Transformation 
Wild-type yeast was grown for 2 days in liquid YEPD media at 23̊ C. A buffer, including 60% 
polyethyleneglycol, 1M lithium acetate, 1M dithiothreitol, and sheared salmon sperm single 
stranded DNA, was added to the wild-type yeast cells. The plasmid was subsequently added. 
Cells were placed in a 45̊ C water bath for 30 minutes. Cells were then plated on media lacking 
uracil and grown at 30̊ C for 2 days.  
 
Fluorescence Microscopy 
Fluorescence microscopy and image capture was done with Nikon90i equipped with a Cool-
SNAP HQ2 digital camera and MetaMorph software (Molecular Devices, Sunnyvale, CA).  
Image processing was performed using Adobe photoshop. 
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Sequencing 
Plasmids were sent to the Plant-Microbe Genomics Facility at The Ohio State University for 
sequencing. Sequences were then compared to the wild-type TRM1 sequence using BLAST to 
define the mutations generated. 
 
Structural Predictions 
We employed the open source PyMol 3-D imaging program to superimpose the generated amino 
acid mutations on the 3-D crystal structure of  the Archea Trm1 (10).  
 
Site-directed Mutagenesis 
Two fragments were generated by PCR amplification using pGEM-T/Trm1-II as the template 
and Pfu Ultra High Fidelity DNA polymerase (Stratagene). The first fragment was generated 
using the T7 primer and the Trm1 primer which contained one of several mutations (see Table 
1). The second fragment was generated using an SP6 primer and the appropriate downstream 
primer for each construct. The purified PCR products were then digested with EcoRI and HindIII 
to remove them from the pGEM-T vector. The fragments were then treated with PNK and ligated 
into a pGP-54a-GFP plasmid that was previously digested with EcoRI and HindIII. (See Fig. 5 
for method) 
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Figure 4: 
 
Figure 4: Method used for random mutagenesis of Trm1(126-151). A.) Generate mutant 
megaprimer. B.) Use mutant megaprimer to generate full length TRM1 with random mutations. 
 
 
 
 
 
 
 
15 
 
 
 
Figure 5 
 
Figure 5: Method used for site-directed mutagenesis. 
 
 
Chapter 3: Results 
Random Mutagenesis Screen 
A random mutagenesis screen was performed in an attempt to further characterize the 
Trm1 (130-151) targeting/tethering motif. The Trm1 amino acid region 126-151 was targeted in 
the random mutagenesis. A library which contained approximately three hundred and sixty 
clones, each presumably containing a random mutation(s) within the Trm1 (126-151) sequence, 
were generated. The plasmid DNA was purified and subsequently transformed into yeast. 
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Fluorescence microscopy was then used to observe the localization of Trm1-GFP protein. The 
wild-type Trm1 protein locates to the periphery of the INM. If a mutation caused a defect in the 
INM targeting/tethering activity of the motif, then the protein would be mislocalized to the 
nucleoplasm. The intention was to determine which amino acid changes do or do not cause a 
defect in the targeting/tethering activity. Approximately one hundred and sixty of the generated 
plasmids were then sequenced, and each sequence was compared to that of wild-type Trm1. Each 
discrepancy between the plasmid sequence and wild-type sequence was analyzed in an attempt to 
determine if an amino acid change occurred. Many clones contained plasmids with a single 
amino acid mutation, while some contained plasmids with double or triple amino acid mutations. 
The plasmids from about one hundred forty different mutants that showed wild-type localization 
of Trm1 were sequenced. Approximately fifty of these plasmids contained an amino acid change, 
and about thirty-five of these changes were new mutations that result in the wild-type 
localization of Trm1. Approximately fifteen plasmids from mutants in which Trm1 was 
mislocalized to the nucleoplasm were sequenced. From these sequences, thirteen new amino acid 
changes were found that cause a defect in the targeting/tethering activity of the Trm1(130-151) 
motif. Every amino acid within the targeted region was mutated, and several of the mutations 
generated within this region cause mislocalization of Trm1 (Fig. 6- lists all amino acid changes 
generated). These data confirm that this specific region is important for INM targeting.  
 
The Trm1 (130-151) motif appears to be structure specific 
The data indicated that the Trm1-II (130-151) region is likely a structural motif. The 
results of the random mutagenesis screen do not indicate that it is necessary for a specific amino 
acid to be present at any of the locations within the motif, so it is unlikely that this is a sequence 
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specific motif. For example, amino acid 148 is an isoleucine in the wild-type Trm1 amino acid 
sequence, and this residue can be changed to serine, asparagine, or threonine and the motif does 
not lose its targeting/tethering activity. This indicates that the presence of an isoleucine is not 
necessary at that location in the sequence. Examples such as amino acid 148 support the idea that 
this motif is not sequence specific.  Instead, it appears that the properties of the amino acids, such 
as size, hydrophobicity, and charge, are important. 
 In order to determine whether or not changes in amino acid properties were caused by 
each of the various mutations, I evaluated and categorized each mutation and naturally occurring 
amino acid by its property (Fig. 7).  Each amino acid was categorized as either hydrophobic 
(AGCVPLIM), hydrophilic-neutral (NQST), positively charged (RKH), negatively charged 
(ED), or bulky/aromatic (WFY). The data generated by the random mutagenesis indicate that 
almost all of the mutations that cause a defect in the Trm1 targeting/tethering motif also create a 
change in the property of the wild-type amino acid. For example, when the property of amino 
acid 151 is changed from hydrophobic to negatively charged, Trm1 is mislocalized. However, 
when this same amino acid is changed to another hydrophobic amino acid, Trm1 localizes to the 
periphery of the INM as if it were wild-type. This supports the idea that the properties of the 
amino acids are important for the maintenance of the targeting/tethering activity of the motif.  It 
is likely the properties of the amino acids that are important, therefore, it is probable that this is a 
structure specific peptide motif. 
 If the data had indicated that this was a sequence specific motif, a possible consensus 
sequence that may have been conserved among other proteins in yeast and in higher eukaryotes 
could have been determined. If a similar sequence existed in other proteins that target to the 
INM, it could have been determined that this sequence specific motif is responsible for INM 
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targeting of peripherally associated proteins. Since the data instead indicated that the motif is 
structure specific, it was necessary to conduct further investigation of the motif to determine 
which properties of the amino acids within the sequence are responsible for maintaining its 
structure.  
 
Structural Predictions 
An amphipathic -helix appears to be important for INM targeting activity 
It was necessary to determine which aspects of the Trm1 structure may be important for 
the INM targeting activity of the 130-151 motif. First, the generated amino acid mutations were 
superimposed on the recently defined Archea structure of Trm1 (Ihsanawati et al., 2008) in an 
attempt to determine the affect of the mutations on the structure of the protein. The region that is 
homologous to TrmI-II (130-151) in yeast was analyzed. The overlay indicated that amino acids 
145-153 make up an α-helix. The helix is part of the motif region that is necessary and sufficient 
for the INM targeting of Trm1-II. Several of the mutations that cause Trm1 mislocalization can 
be found in the region that makes up the α- helix, so it is probable that this component of the 
Trm1 structure is important for its targeting to the periphery of the INM.  Since this α-helix 
appeared to be important, further analysis of the 145-153 region was conducted. When analyzing 
the amino acids that make up this helix, it was realized that this helix is amphipathic. A helical 
wheel was used to visualize the composition of the helix formed by amino acids 145-153 (Fig. 
8). The helical wheel indicates that this helix has four polar amino acids (R146, R149, E153, and 
Y150) on one side and three nonpolar amino acids (A147, A151, and I148) on the other side. The 
next step was to determine whether or not the amino acid changes within the helical region that 
cause Trm1 mislocalization result in a change in amino acid property. Analysis revealed that all 
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of the mutations within the 145-151 amino acid region resulted in a deviation from the property 
of the wild-type amino acid. Moreover, the data indicate that amino acid changes that altered the 
amphipathic property of the -helix resulted in the mislocalization of Trm1-II to the 
nuceloplasm. For example, a mutation that changed the polar amino acid arginine (residue 146) 
to the nonpolar amino acid serine caused mislocalization. Conversely, a mutation that changed 
the nonpolar amino acid alanine (residue 147) to the negatively charged polar amino acid 
aspartate also caused mislocalization of Trm1 to the nucleoplasm. Since the destruction of the 
amphipathic property of the helix appears to cause a defect in the targeting/tethering motif , a 
model in which the amphpathic property of the -helix is important for INM targeting/tethering 
activity was proposed.  
 
Bulky residues may interfere with Trm1(130-151) targeting activity 
Based on the results of the random mutagenesis screen, we have also determined that 
amino acid changes resulting in a bulky or aromatic amino acid likely destroy the INM 
localization of Trm1-II. For example, a mutation that changed the small amino acid isoleucine 
(residue 148) to the bulky amino acid phenyalanine caused Trm1 to mislocalize to the 
nucleoplasm. These data suggest that the size of each individual amino acid is also important for 
Trm1-II targeting to the INM.  
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Site-directed Mutagenesis  
 In an attempt to test the model that was generated based on the results of the random 
mutagenesis screen, I am currently performing site-directed mutagenesis on specific amino acid 
residues that are part of the -helix.  The goal is to generate various mutations that will cause 
amino acid changes that will result in the destruction of the amphipathic property of the -helix. 
For example, one of the site-directed mutations will cause the nonpolar amino acid alanine 
(residue 147) to change to the polar residue lysine. Another site-directed mutation will change 
the polar, positively charged amino acid arginine (residue 145) to the nonpolar amino acid serine. 
In addition to creating mutations that destroy the amphipathicity of the -helix, mutations will 
also be made that cause small amino acids to be changed to bulky amino acids (such as 
phenylalanine and tryptophan). For example, one of the site-directed mutations will change the 
small amino acid alanine (residue 147) to the bulky amino acid tryptophan.  
 I have designed primers that will create nine different amino changes within the helical 
region (refer to table 1 for primers). Each individual mutation is being generated using the 
technique described in materials and methods for site-directed mutagenesis. Once plasmids 
containing the specific mutations are created and transformed into yeast, the localization of 
Trm1-GFP will be observed using fluorescence microscopy. The effect of the various mutations 
on the localization of Trm1-II to the INM will be determined. If mutations that alter the 
amphipathic property of the Trm1(145-153) α- helix cause mislocalization to the nucleoplasm, 
then there will be evidence that the amphipathic property is important for the targeting activity of 
Trm1-II.  If bulky residues cause the mislocalization of Trm1-II to the nucleoplasm, then there 
will be evidence that the size of the amino acids is also important for INM targeting. 
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Figure 6 
A. 
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B.    
 
 
Figure 6: Mutations that do or do not alter Trm1 INM localization. A. A diagram of the mutations 
analyzed. Green box indicates the area of Trm1 in eukaryotic but not Archael counterparts; 
Magenta box indicates sequences highly conserved in all Trm1 proteins. The area of Trm1 that 
was subject to a random mutagenesis is indicated in bold. The underlined region indicates the 
amino acids that make up the amphipathic α-helix. Mutations that alter the location of Trm1-II 
GFP are shown above the wild-type sequence, and those that do not alter the location are shown 
below. (Black-single mutations ; color coordinated multiple mutations) B. Sample data for the 
random mutagenesis mutations: 1, wild-type Trm1-II- GFP; 2, mutation of amino acid (P132T) 
does not affect Trm1-II-GFP subnuclear location; 3 and 4 single (A151D) and double mutations 
(P131S, G144R) cause Trm1-II-GFP to mislocalize to the nucleoplasm. 
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Figure 7 
 
 
Figure 7: Changes in amino acid properties: Amino acids are listed by their property as indicated in the 
key. All other aspects of the figure remain the same as Figure 4A.  
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Figure 8 
 
  A. 
                                 
B.    
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Figure 8: A. Ribbon structure of Archea Trm1. The helix generated by Trm1 amino acids 145-153 is 
indicated in purple. B. Helical wheel demonstrating the amphipathic property of the helix. (1=amino acid 
145). The right side of the helix is composed of polar residues and the left side is composed of nonpolar 
residues.  Some amino acid changes within the helix that cause Trm1 to mislocalize to the nucleoplasm 
are indicated.  
 
 
Chapter 4: Discussion 
 
The proper subcellular localization of proteins is often essential to their function. While there is 
some understanding about the mechanism by which integral membrane proteins target to the inner nuclear 
membrane, very little is known about how peripherally associated proteins target to the INM. Recent 
research in Saccharomyces cerevisiae has demonstrated that Trm1, a tRNA methyltransferase, has a 
cis-acting peptide motif, Trm1(130-151), that is necessary and sufficient for its targeting to the INM. This 
research was a starting point for understanding a mechanism by which peripherally associated proteins 
target to and are retained at the inner nuclear membrane. In the work reported here, the Trm1 
targeting/tethering motif was further characterized, and a model has been proposed where the amphipathic 
property of the α-helix that is part of the motif is important for INM targeting. It is possible that other 
INM proteins in yeast, and higher eukaryotes, may contain a similar motif. If this is the case, it can be 
determined if this model is generally applicable to other proteins that target to the periphery of the INM. 
 In the work reported here, the Trm1(130-151) peptide motif was subjected to a random 
mutagenesis screen. About thirteen new mutations that cause Trm1 to mislocalize to the nucleoplasm and 
approximately thirty-five mutations that allow Trm1 to localize to the INM as if it were wild-type were 
characterized. Analysis of the results of the random mutagenesis screen indicated that a sequence specific 
motif is unlikely. The structure of the motif, especially the amphipathic helix, appears to be important for 
proper INM localization.   
 Further investigation of the effects of the various mutations on the structure of the Trm1 
targeting/tethering motif was carried out. The structural analysis revealed that Trm1 amino acids 145-153 
are predicted to form an amphipathic α-helix. The helix is part of the region that has been shown to be 
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necessary and sufficient for the INM targeting of Trm1. Mutations that destroyed the amphipathic 
property of the helix caused Trm1 to mislocalize to the nucleoplasm. Based on these data, I propose that 
the amphipathic property of the Trm1(145-153) α-helix is important for the targeting activity of the motif. 
In addition to the importance of the amphipathic property, the data also suggests that the size of the amino 
acid acids may be important for the peptide motif’s targeting activity.  
 In order to test the proposed model in which the amphipathic property of the α-helix is important 
for the targeting/tethering activity of the Trm1(130-151) motif, site-directed mutagenesis is currently 
being performed. This experiment aims to generate a series of mutations that destroy the amphipathic 
properties of the helix. If the destruction of this property causes mislocalization of Trm1-II, it would 
suggest that the amphipathic property of the helix is important for the proper targeting of Trm1-II to the 
INM. A second set of mutations will change the size of some specific amino acids from small to bulky 
residues. This will test the idea that the size of the amino acids is also important for INM targeting.  
 No other motifs have been proposed for the targeting of peripherally associated proteins to the 
INM. The Trm1(130-151) cis-acting peptide motif is the first of its kind to be discovered. It is proposed 
here that the amphipathic α-helix is a component of this motif that has significant importance for its 
targeting activity. It is possible that other peripherally associated INM proteins contain a similar region. 
In the future, genome databases can be used to search for similar amphipathic α-helices in other 
peripherally associated INM proteins in yeast and in higher eukaryotes. Such proteins can then 
be studied to test whether or not the identified amphipatic α-helices function in INM targeting in 
the relevant proteins and in reporter proteins. If similar function structures are found in other 
proteins, then it can be concluded that the importance of the amphipathic helix in the targeting 
motif is not Trm1 specific and that we have uncovered a general mechanism for 
tethering/targeting of proteins to this important subnuclear location.  The results obtained from 
this research have significantly contributed to the understanding of the targeting of peripherally 
associated proteins to the INM and may possibly have medical implications in the future.  
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